Details for New Drug Application (NDA): 206095
✉ Email this page to a colleague
NDA 206095 describes DEXTROAMPHETAMINE SULFATE, which is a drug marketed by Able, Actavis Elizabeth, Dr Reddys Labs Sa, Nesher Pharms, Norvium Bioscience, Specgx Llc, Strides Pharma, Prasco, Tris Pharma Inc, Ani Pharms, Aurolife Pharma Llc, Avanthi Inc, Azurity, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Nuvo Pharm, Purepac Pharm, Sandoz, Vitarine, and Winder Labs Llc, and is included in thirty-three NDAs. It is available from fourteen suppliers. Additional details are available on the DEXTROAMPHETAMINE SULFATE profile page.
The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for 206095
| Tradename: | DEXTROAMPHETAMINE SULFATE |
| Applicant: | Tris Pharma Inc |
| Ingredient: | dextroamphetamine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 206095
| Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 206095
Suppliers and Packaging for NDA: 206095
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 206095 | ANDA | Tris Pharma Inc | 27808-089 | 27808-089-01 | 100 TABLET in 1 BOTTLE, PLASTIC (27808-089-01) |
| DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 206095 | ANDA | Tris Pharma Inc | 27808-090 | 27808-090-01 | 100 TABLET in 1 BOTTLE, PLASTIC (27808-090-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Aug 18, 2022 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Aug 18, 2022 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
